Newborn Hearing Screening in Neonates Exposed to Psychoactive Drugs

Detalhes bibliográficos
Autor(a) principal: Rocha,Bruna Salazar Castro da
Data de Publicação: 2014
Outros Autores: Machado,Márcia Salgado, Zanini,Cláudia Fernandes Costa, Paniz,Tatiana de Carvalho, Menegotto,Isabela Hoffmeister
Tipo de documento: Artigo
Idioma: eng
Título da fonte: International Archives of Otorhinolaryngology
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642014000100043
Resumo: Introduction  In pregnancy, the mother and fetus share body structures based on the maternal organism. Exposure to psychoactive drugs in this period may have repercussions on the baby's hearing. Therefore, it is necessary to investigate this association. Aim  Analyze the results of newborn hearing screening (NHS), the occurrence of associated risk factors, and the incidence of hearing loss in newborn exposed to psychoactive drugs during pregnancy. Methods  This is an observational retrospective study done from a database analysis. From this database, records were selected about the use of psychoactive drugs by mothers during pregnancy, then the neonates were divide into two groups: the study group (146 babies exposed to drugs) and the control group (500 babies not exposed to drugs). The NHS failure rate, the presence of risk factors for hearing loss, and need for audiological diagnosis were analyzed in both groups. From these variables, absolute frequency and prevalence rates were calculated and the results compared between groups. Results  There was no statistically significant difference in the comparison of NHS failure rates between the groups (p = 0.267). The occurrence of risk factors for hearing loss was greater in babies exposed to drugs (p < 0.0001). There was only one diagnosis of hearing loss, which occurred in the control group (p = 0.667). Conclusion  The use of psychoactive drugs by mothers during pregnancy did not affect the NHS failure rate of this sample. However, the occurrence of significant risk factors in the study group showed a possible sensitivity of babies exposed to psychoactive drugs during pregnancy.
id FORL-1_3f506c1aaf8d06166226169346fa8f94
oai_identifier_str oai:scielo:S1809-48642014000100043
network_acronym_str FORL-1
network_name_str International Archives of Otorhinolaryngology
repository_id_str
spelling Newborn Hearing Screening in Neonates Exposed to Psychoactive Drugsnewborn screeningpsychotropic drugshearing Introduction  In pregnancy, the mother and fetus share body structures based on the maternal organism. Exposure to psychoactive drugs in this period may have repercussions on the baby's hearing. Therefore, it is necessary to investigate this association. Aim  Analyze the results of newborn hearing screening (NHS), the occurrence of associated risk factors, and the incidence of hearing loss in newborn exposed to psychoactive drugs during pregnancy. Methods  This is an observational retrospective study done from a database analysis. From this database, records were selected about the use of psychoactive drugs by mothers during pregnancy, then the neonates were divide into two groups: the study group (146 babies exposed to drugs) and the control group (500 babies not exposed to drugs). The NHS failure rate, the presence of risk factors for hearing loss, and need for audiological diagnosis were analyzed in both groups. From these variables, absolute frequency and prevalence rates were calculated and the results compared between groups. Results  There was no statistically significant difference in the comparison of NHS failure rates between the groups (p = 0.267). The occurrence of risk factors for hearing loss was greater in babies exposed to drugs (p < 0.0001). There was only one diagnosis of hearing loss, which occurred in the control group (p = 0.667). Conclusion  The use of psychoactive drugs by mothers during pregnancy did not affect the NHS failure rate of this sample. However, the occurrence of significant risk factors in the study group showed a possible sensitivity of babies exposed to psychoactive drugs during pregnancy. Fundação Otorrinolaringologia2014-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642014000100043International Archives of Otorhinolaryngology v.18 n.1 2014reponame:International Archives of Otorhinolaryngologyinstname:Fundação Otorrinolaringologia (FORL)instacron:FORL10.1055/s-0033-1358579info:eu-repo/semantics/openAccessRocha,Bruna Salazar Castro daMachado,Márcia SalgadoZanini,Cláudia Fernandes CostaPaniz,Tatiana de CarvalhoMenegotto,Isabela Hoffmeistereng2015-08-24T00:00:00Zoai:scielo:S1809-48642014000100043Revistahttps://www.scielo.br/j/iao/https://old.scielo.br/oai/scielo-oai.php||iaorl@iaorl.org||archives@internationalarchivesent.org||arquivos@forl.org.br1809-48641809-4864opendoar:2015-08-24T00:00International Archives of Otorhinolaryngology - Fundação Otorrinolaringologia (FORL)false
dc.title.none.fl_str_mv Newborn Hearing Screening in Neonates Exposed to Psychoactive Drugs
title Newborn Hearing Screening in Neonates Exposed to Psychoactive Drugs
spellingShingle Newborn Hearing Screening in Neonates Exposed to Psychoactive Drugs
Rocha,Bruna Salazar Castro da
newborn screening
psychotropic drugs
hearing
title_short Newborn Hearing Screening in Neonates Exposed to Psychoactive Drugs
title_full Newborn Hearing Screening in Neonates Exposed to Psychoactive Drugs
title_fullStr Newborn Hearing Screening in Neonates Exposed to Psychoactive Drugs
title_full_unstemmed Newborn Hearing Screening in Neonates Exposed to Psychoactive Drugs
title_sort Newborn Hearing Screening in Neonates Exposed to Psychoactive Drugs
author Rocha,Bruna Salazar Castro da
author_facet Rocha,Bruna Salazar Castro da
Machado,Márcia Salgado
Zanini,Cláudia Fernandes Costa
Paniz,Tatiana de Carvalho
Menegotto,Isabela Hoffmeister
author_role author
author2 Machado,Márcia Salgado
Zanini,Cláudia Fernandes Costa
Paniz,Tatiana de Carvalho
Menegotto,Isabela Hoffmeister
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Rocha,Bruna Salazar Castro da
Machado,Márcia Salgado
Zanini,Cláudia Fernandes Costa
Paniz,Tatiana de Carvalho
Menegotto,Isabela Hoffmeister
dc.subject.por.fl_str_mv newborn screening
psychotropic drugs
hearing
topic newborn screening
psychotropic drugs
hearing
description Introduction  In pregnancy, the mother and fetus share body structures based on the maternal organism. Exposure to psychoactive drugs in this period may have repercussions on the baby's hearing. Therefore, it is necessary to investigate this association. Aim  Analyze the results of newborn hearing screening (NHS), the occurrence of associated risk factors, and the incidence of hearing loss in newborn exposed to psychoactive drugs during pregnancy. Methods  This is an observational retrospective study done from a database analysis. From this database, records were selected about the use of psychoactive drugs by mothers during pregnancy, then the neonates were divide into two groups: the study group (146 babies exposed to drugs) and the control group (500 babies not exposed to drugs). The NHS failure rate, the presence of risk factors for hearing loss, and need for audiological diagnosis were analyzed in both groups. From these variables, absolute frequency and prevalence rates were calculated and the results compared between groups. Results  There was no statistically significant difference in the comparison of NHS failure rates between the groups (p = 0.267). The occurrence of risk factors for hearing loss was greater in babies exposed to drugs (p < 0.0001). There was only one diagnosis of hearing loss, which occurred in the control group (p = 0.667). Conclusion  The use of psychoactive drugs by mothers during pregnancy did not affect the NHS failure rate of this sample. However, the occurrence of significant risk factors in the study group showed a possible sensitivity of babies exposed to psychoactive drugs during pregnancy.
publishDate 2014
dc.date.none.fl_str_mv 2014-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642014000100043
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1809-48642014000100043
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1055/s-0033-1358579
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Fundação Otorrinolaringologia
publisher.none.fl_str_mv Fundação Otorrinolaringologia
dc.source.none.fl_str_mv International Archives of Otorhinolaryngology v.18 n.1 2014
reponame:International Archives of Otorhinolaryngology
instname:Fundação Otorrinolaringologia (FORL)
instacron:FORL
instname_str Fundação Otorrinolaringologia (FORL)
instacron_str FORL
institution FORL
reponame_str International Archives of Otorhinolaryngology
collection International Archives of Otorhinolaryngology
repository.name.fl_str_mv International Archives of Otorhinolaryngology - Fundação Otorrinolaringologia (FORL)
repository.mail.fl_str_mv ||iaorl@iaorl.org||archives@internationalarchivesent.org||arquivos@forl.org.br
_version_ 1754203974813089792